10-Q Filing

HealthLynked Corp CIK: 1680139 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-048070`
Period End Date	20220630
Filing Date	20220815
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	f10q0622_healthlynked_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 85 Income Statement 106 Cash Flow Statement 86 Stockholders Equity 41

Balance Sheet 85 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashEquivalentsAtCarryingValue`	$3.29M	USD	Point-in-time
Cash	`CashEquivalentsAtCarryingValue`	$251.12K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $-0- and $13,972 as of June 30, 2022 and December 31, 2021, respectively	`AccountsReceivableNetCurrent`	$86.29K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $-0- and $13,972 as of June 30, 2022 and December 31, 2021, respectively	`AccountsReceivableNetCurrent`	$90.08K	USD	Point-in-time
Inventory	`InventoryNet`	$182.94K	USD	Point-in-time
Inventory	`InventoryNet`	$134.93K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$137.63K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$74.63K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$598.77K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.65M	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $338,448 and $283,512 as of June 30, 2022 and December 31, 2021, respectively	`PropertyPlantAndEquipmentNet`	$471.87K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $338,448 and $283,512 as of June 30, 2022 and December 31, 2021, respectively	`PropertyPlantAndEquipmentNet`	$350.48K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$283.51K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$338.45K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $1,231,283 and $873,417 as of June 30, 2022 and December 31, 2021, respectively	`FiniteLivedIntangibleAssetsNet`	$4.88M	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$873.42K	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.23M	USD	Point-in-time
Intangible assets, net of accumulated amortization of $1,231,283 and $873,417 as of June 30, 2022 and December 31, 2021, respectively	`FiniteLivedIntangibleAssetsNet`	$4.52M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Goodwill	`Goodwill`	$1.48M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Right of use lease assets	`OperatingLeaseRightOfUseAsset`	$526.73K	USD	Point-in-time
Right of use lease assets	`OperatingLeaseRightOfUseAsset`	$80.26K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Right of use lease assets	`OperatingLeaseRightOfUseAsset`	$728.92K	USD	Point-in-time
Deferred equity compensation and deposits	`DeferredEquityCompensationAndDeposit`	$138.62K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	239.08M	shares	Point-in-time
Deferred equity compensation and deposits	`DeferredEquityCompensationAndDeposit`	$116.75K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	237.89M	shares	Point-in-time
Total Assets	`Assets`	$10.69M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	237.89M	shares	Point-in-time
Total Assets	`Assets`	$7.92M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	239.08M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$790.84K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$971.99K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$72.84K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$37.64K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$385.75K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$288.97K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockParValue`	$0.00	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockParValue`	$0.00	USD	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	-	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	719,366.00	shares	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	$40.52K	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	1.21M	shares	Point-in-time
Liability-classified equity instruments, current portion	`LiabilityclassifiedEquityInstrumentsCurrentPortion`	$61.25K	USD	Point-in-time
Liability-classified equity instruments, current portion	`LiabilityclassifiedEquityInstrumentsCurrentPortion`	$35.00K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$403.47K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$208.44K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.92M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.98M	USD	Point-in-time
Government notes payable, long term portion	`GovernmentAndVendorNotesPayableLongTermPortion`	$450.00K	USD	Point-in-time
Government notes payable, long term portion	`GovernmentAndVendorNotesPayableLongTermPortion`	$450.00K	USD	Point-in-time
Liability-classified equity instruments, long term portion	`LongTermDebtNoncurrent`	$101.25K	USD	Point-in-time
Liability-classified equity instruments, long term portion	`LongTermDebtNoncurrent`	$101.25K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$782.22K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$237.78K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$239.22K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$345.24K	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.49M	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.11M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 239,080,428 and 237,893,473 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$23.79K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 239,080,428 and 237,893,473 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$23.91K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 1,207,472 and 719,366 shares as of June 30, 2022 and December 31, 2021, respectively	`CommonStockIssuableValue`	$345.04K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 1,207,472 and 719,366 shares as of June 30, 2022 and December 31, 2021, respectively	`CommonStockIssuableValue`	$282.35K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$39.40M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$39.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.21M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-34.96M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$4.80M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.17M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.30M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.14M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$1.35M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$7.20M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$10.69M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$7.92M	USD	Point-in-time

Income Statement 106 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.98M	USD	2 Qtrs
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.43M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.81M	USD	2 Qtrs
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.47M	USD	1 Quarter
Subscription, consulting and event revenue	`SubscriptionConsultingAndEventRevenue`	$-71.86K	USD	1 Quarter
Subscription, consulting and event revenue	`SubscriptionConsultingAndEventRevenue`	$-170.51K	USD	2 Qtrs
Subscription, consulting and event revenue	`SubscriptionConsultingAndEventRevenue`	$-86.30K	USD	1 Quarter
Subscription, consulting and event revenue	`SubscriptionConsultingAndEventRevenue`	$-159.52K	USD	2 Qtrs
Product revenue	`ProductRevenue`	$168.21K	USD	1 Quarter
Product revenue	`ProductRevenue`	$277.43K	USD	2 Qtrs
Product revenue	`ProductRevenue`	$130.46K	USD	1 Quarter
Product revenue	`ProductRevenue`	$350.87K	USD	2 Qtrs
Total revenue	`Revenues`	$1.71M	USD	1 Quarter
Total revenue	`Revenues`	$3.26M	USD	2 Qtrs
Total revenue	`Revenues`	$3.50M	USD	2 Qtrs
Total revenue	`Revenues`	$1.65M	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$816.40K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$903.03K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$1.57M	USD	2 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$1.53M	USD	2 Qtrs
Other practice operating expenses	`OtherCostAndExpenseOperating`	$1.20M	USD	2 Qtrs
Other practice operating expenses	`OtherCostAndExpenseOperating`	$1.24M	USD	2 Qtrs
Other practice operating expenses	`OtherCostAndExpenseOperating`	$639.12K	USD	1 Quarter
Other practice operating expenses	`OtherCostAndExpenseOperating`	$511.00K	USD	1 Quarter
Medicare shared savings expenses	`MedicareSharedSavingsExpenses`	$408.97K	USD	2 Qtrs
Medicare shared savings expenses	`MedicareSharedSavingsExpenses`	$464.88K	USD	2 Qtrs
Medicare shared savings expenses	`MedicareSharedSavingsExpenses`	$197.46K	USD	1 Quarter
Medicare shared savings expenses	`MedicareSharedSavingsExpenses`	$237.15K	USD	1 Quarter
Cost of product revenue	`CostOfProductRevenue`	$170.54K	USD	1 Quarter
Cost of product revenue	`CostOfProductRevenue`	$328.59K	USD	2 Qtrs
Cost of product revenue	`CostOfProductRevenue`	$160.00K	USD	1 Quarter
Cost of product revenue	`CostOfProductRevenue`	$331.35K	USD	2 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.59M	USD	2 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.15M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.51M	USD	2 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.26M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$418.13K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$206.47K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$208.91K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$412.80K	USD	2 Qtrs
Total Operating Expenses and Costs	`OperatingExpenses`	$3.33M	USD	1 Quarter
Total Operating Expenses and Costs	`OperatingExpenses`	$6.54M	USD	2 Qtrs
Total Operating Expenses and Costs	`OperatingExpenses`	$3.13M	USD	1 Quarter
Total Operating Expenses and Costs	`OperatingExpenses`	$6.48M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.28M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.98M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.68M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.41M	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$632.83K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	2 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-19.25K	USD	2 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$274.61K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-361.09K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$532.09K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$93.77K	USD	1 Quarter
Interest (expense) income	`NonoperatingIncomeExpense`	$-4.49K	USD	1 Quarter
Interest (expense) income	`NonoperatingIncomeExpense`	$-9.51K	USD	2 Qtrs
Interest (expense) income	`NonoperatingIncomeExpense`	$-8.96K	USD	2 Qtrs
Interest (expense) income	`NonoperatingIncomeExpense`	$1.62K	USD	1 Quarter
Total other income (expenses)	`OtherOperatingIncomeExpenseNet`	$-5.35M	USD	2 Qtrs
Total other income (expenses)	`OtherOperatingIncomeExpenseNet`	$522.58K	USD	2 Qtrs
Total other income (expenses)	`OtherOperatingIncomeExpenseNet`	$89.28K	USD	1 Quarter
Total other income (expenses)	`OtherOperatingIncomeExpenseNet`	$909.06K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.76M	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-505.76K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.33M	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.59M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-505.76K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.76M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.33M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.17M	USD	1 Quarter
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$176.79K	USD	2 Qtrs
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$176.79K	USD	2 Qtrs
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$88.39K	USD	1 Quarter
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$88.39K	USD	1 Quarter
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.51M	USD	2 Qtrs
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.93M	USD	2 Qtrs
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-594.16K	USD	1 Quarter
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.68M	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.04	USD	2 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.04	USD	2 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	238.30M	shares	2 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	228.01M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	220.82M	shares	2 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	238.60M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	238.60M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	228.01M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	238.30M	shares	2 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	220.82M	shares	2 Qtrs

Cash Flow Statement 86 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-505.76K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.76M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.33M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.17M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$418.13K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$206.47K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$208.91K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$412.80K	USD	2 Qtrs
Stock based compensation, including amortization of deferred equity compensation	`EmployeeBenefitsAndShareBasedCompensation`	$461.22K	USD	2 Qtrs
Stock based compensation, including amortization of deferred equity compensation	`EmployeeBenefitsAndShareBasedCompensation`	$261.72K	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$632.83K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	2 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-19.25K	USD	2 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$-361.09K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$532.09K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.58K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.79K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$17.52K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$48.01K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$23.12K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-41.75K	USD	2 Qtrs
Right of use lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$162.98K	USD	2 Qtrs
Right of use lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$50.45K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-90.49K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$142.01K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$162.38K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$52.31K	USD	2 Qtrs
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-35.20K	USD	2 Qtrs
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-18.58K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.52M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.26M	USD	2 Qtrs
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$300.92K	USD	2 Qtrs
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$196.00K	USD	2 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$207.38K	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.40K	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.56K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-203.40K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-531.86K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.00K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$4.65M	USD	2 Qtrs
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	-	USD	2 Qtrs
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	$293.95K	USD	2 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	$512.00	USD	2 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	$51.11K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.49K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.89M	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.43M	USD	2 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.04M	USD	2 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$251.12K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.59M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$162.18K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$251.12K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.59M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$162.18K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$232.00	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$1.13K	USD	2 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	2 Qtrs
Fair value of shares issued as purchase price consideration	`FairValueAdjustmentOfWarrants`	$103.80K	USD	2 Qtrs
Fair value of shares issued as purchase price consideration	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$69.03K	USD	2 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$187.00K	USD	2 Qtrs
Fair value of liability-classified equity instruments cancelled (net of earned)	`FairValueOfMarketableSecuritiesReceived`	-	USD	2 Qtrs
Fair value of liability-classified equity instruments cancelled (net of earned)	`FairValueOfMarketableSecuritiesReceived`	$26.25K	USD	2 Qtrs
Recognition of operating lease: right of use asset and lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Recognition of operating lease: right of use asset and lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$284.90K	USD	2 Qtrs
Fair value of warrants issued for professional service	`StockIssued1`	-	USD	2 Qtrs
Fair value of warrants issued for professional service	`StockIssued1`	$32.43K	USD	2 Qtrs
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	$126.50K	USD	Point-in-time
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	-	USD	Point-in-time
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$4.06M	USD	2 Qtrs
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	-	USD	2 Qtrs
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	-	USD	Point-in-time
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	$3.07M	USD	Point-in-time
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	-	USD	2 Qtrs
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	$614.22K	USD	2 Qtrs

Stockholders Equity 41 line items

Line Item	Tag	Value	Unit	Period
Balance at	`StockholdersEquity`	$4.80M	USD	Point-in-time
Balance at	`StockholdersEquity`	$6.17M	USD	Point-in-time
Balance at	`StockholdersEquity`	$6.30M	USD	Point-in-time
Balance at	`StockholdersEquity`	$6.14M	USD	Point-in-time
Balance at	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance at	`StockholdersEquity`	$7.20M	USD	Point-in-time
Sales of common stock	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$8.28K	USD	1 Quarter
Sales of common stock	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$177.68K	USD	1 Quarter
Sales of common stock	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$2.98M	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockIssuedDuringPeriodValueOther`	$82.32K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockIssuedDuringPeriodValueOther`	$1.72K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockIssuedDuringPeriodValueOther`	$1.41M	USD	1 Quarter
Shares issued in acquisition of AEU	`StockIssuedDuringPeriodValueAcquisitions`	$103.80K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$4.06M	USD	1 Quarter
Fair value of warrants issued in connection with conversion and retirement of convertible notes payable	`FairValueOfWarrantsIssuedAndModifiedInConnectionWithConversionAndRetirementOfConve`	$3.20M	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$3.60K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$32.43K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$86.81K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$105.43K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$237.33K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$81.52K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$63.66K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$37.41K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$215.00K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$676.72K	USD	1 Quarter
Shares and options issued to employees	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$26.78K	USD	1 Quarter
Shares and options issued to employees	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$31.12K	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	$3.15K	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	$13.30K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-505.76K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.76M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.33M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.17M	USD	1 Quarter
Balance at	`StockholdersEquity`	$4.80M	USD	Point-in-time
Balance at	`StockholdersEquity`	$6.17M	USD	Point-in-time
Balance at	`StockholdersEquity`	$6.30M	USD	Point-in-time
Balance at	`StockholdersEquity`	$6.14M	USD	Point-in-time
Balance at	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance at	`StockholdersEquity`	$7.20M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.